slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
214,741-214,800 of 319,975
17
The slide uses a timeline format to show product development stages and commercial launch milestones.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
18
Slide 18 of a pitch deck.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
19
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · CompetitionLoop · Golden Circle1 hit
20
The timeline uses a DNA helix motif to represent the company's focus on molecular diagnostics.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
21
Includes unaudited financial results, balance sheet data, and equity information.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
22
The slide uses a grid layout to display headshots, names, titles, and company logos for 9 executives.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · TeamLoop · Golden Circle1 hit
23
The slide uses a grid layout to present 10 advisors, each with a headshot, name, role, and company/institution logo.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · TeamLoop · Golden Circle1 hit
24
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
25
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
01
Features a collage of product and usage imagery in a cylindrical layout.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations 1 hit
02
Markforged | Results Presentation Deck | 16 slidesMarkforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations 1 hit
03
The slide uses a strong visual metaphor of a 'Print' button to represent the simplicity of modern manufacturing.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · Attention1 hit
04
Uses a Venn-style diagram to show segment TAMs within the context of the global market.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · InterestLoop · Logic Chain1 hit
05
Hub-and-spoke diagram showing the three pillars of the platform.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a circular flywheel diagram to explain the business model's self-reinforcing nature.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
07
The slide uses a three-column layout to present customer success stories with quotes and quantitative growth metrics.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
08
The slide uses a dark background with high-contrast yellow text for emphasis on key metrics.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
09
The chart uses a bar-horizontal format to compare material strength, highlighting the performance of CFR.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
10
The slide uses a timeline-based layout to showcase product innovation and portfolio expansion.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
11
The slide uses a logo-grid layout organized by industry vertical.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
12
Markforged | Results Presentation Deck | 16 slidesMarkforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
13
The slide uses a grid layout to display 11 executive profiles.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · Action1 hit
14
Markforged | Results Presentation Deck | 16 slidesMarkforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · Action1 hit
15
Includes adjustments for warrant liabilities, contingent earnout liabilities, and other operating expenses.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations 1 hit
16
This is a branding or transition slide.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations 1 hit
01
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
02
The slide uses a three-column layout to contrast the lead asset with the two core technology platforms.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
03
The chart uses a Gantt-style visualization to show progress across discovery, preclinical, and clinical phases.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
04
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
QIDP stands for Qualified Infectious Disease Product.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Uses a 'Before-After-Bridge' style logic to frame the solution.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Uses a process/timeline diagram to show life cycle management.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide highlights business development traction through licensing agreements.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart displays survival percentages with corresponding n/N values below each bar group.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
11
The slide uses a timeline-like visualization for each patient to show the rapid decline of fungal load over a short period (12-14 days).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
12
The slide uses a timeline-based process diagram to illustrate the clinical trial protocol.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
13
IFIs stands for Invasive Fungal Infections.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
14
Case study table showing patient demographics, medical history, and treatment outcomes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
15
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
16
The slide serves as a transition to the technology/pipeline section of the deck.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
17
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
18
Includes a scientific diagram of the LNC structure and a list of key performance attributes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
19
The slide uses a process diagram to show the self-assembly of lipoplexes into PS-NPs.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
20
Technical slide detailing biological mechanism of drug delivery platform.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
21
Uses a process-flow diagram to represent maturity levels (Proven, Under Evaluation, Future).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
The slide compares Matinas' PS-NP technology stability (17 weeks) against Moderna (30 days) and Pfizer/BioNTech (10 weeks) at refrigerated temperatures.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The slide shows quantitative radiance data (p/s/cm²/sr) comparing control groups to PS-NP LUC mRNA groups at various time points.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
24
The slide highlights a partnership with 'Resilience' to scale manufacturing for Matinas Biopharma's therapeutic platforms.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
25
The slide uses a grid-based timeline format to track specific technical achievements and partnership milestones.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
The slide uses a three-column icon-based layout to summarize key IP milestones.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Team1 hit
28
The slide uses a split-layout: left side for financial summary, right side for milestones and thesis components.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
01
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
02
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations 1 hit
03
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
04
The chart compares 2022 and 2023 quarterly container volumes, with a specific callout for the Q2 YoY decline.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
Includes a dual-axis line chart and a summary table of economic projections.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The chart compares 2022 vs 2023 quarterly container volumes.Matson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Matson | Results Presentation Deck | 19 slidesMatson | Results Presentation Deck | 19 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit